RAIW CORA : RBCC: Biotech Growing Faster than any Other Sector in Houston
01/17/2012 | 05:05am
When Rainbow Coral Corp. (OTCBB:RBCC) moved its biosciences division to
Houston, Texas, it tapped into an economic hot bed. According to local
economists, Houston's biotechnology sector outpaced every other sector
of the city's economy last year.
One of the main drivers of the biotech industry's success in Houston is
the unique synergy between its healthcare and research institutions.
Home to the largest medical center in the world, Houston offers a strong
foundation of academic institutions, research centers, hospitals and
clinics where health care professionals train and work. It's the ideal
setting for a new company like RBCC looking to tap into the heart of
American biotech innovation.
RBCC's rapidly growing business network in the region opens the door for
the company to become a global player in biotech. Last week, the company
proudly announced its new membership in BioHouston, a
biotech consortium committed to helping Houston organizations facilitate
technology transfer and research commercialization. There is no better
group in the U.S. at helping emerging companies become global
competitors in life science commercialization.
Thanks to the advanced thinking of some of the country's top research
universities and creative entrepreneurs, RBCC is extremely optimistic
that Houston's biotech sector will continue to be tops in the region.
The city offers the resources, culture and networks that RBCC needs to
take a great idea from the laboratory to the marketplace.
For more information on Rainbow BioSciences, RBCC's biotechnology
division, please visit www.rainbowbiosciences.com/investors.
Rainbow BioSciences is working to develop new medical and research
technology innovations to compete alongside companies such as Biogen
Idec Inc. (NASDAQ: BIIB), Abbott Laboratories (NYSE: ABT) Amgen, Inc.
(NASDAQ: AMGN) and Celgene Corp. (NASDAQ: CELG).
Follow us on Twitter at www.twitter.com/RBCCinfo.
About Rainbow BioSciences
Rainbow BioSciences is a division of Rainbow Coral Corp. (OTCBB: RBCC).
The company continually seeks out new partnerships with biotechnology
developers to deliver profitable new medical technologies and
innovations. For more information on our growth-oriented business
initiatives, please visit our website at [www.rainbowbiosciences.com].
For investment information and performance data on the company, please
visit www.RainbowBioSciences.com/investors.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995: This news release contains forward-looking information within
the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended,
including statements that include the words "believes," "expects,"
"anticipate" or similar expressions. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors that
may cause the actual results, performance or achievements of the company
to differ materially from those expressed or implied by such
forward-looking statements. In addition, description of anyone's past
success, either financial or strategic, is no guarantee of future
success. This news release speaks as of the date first set forth above
and the company assumes no responsibility to update the information
included herein for events occurring after the date hereof.
Rainbow Coral Corp.
Patrick Brown, 813-367-9511
President and
CEO
info@rainbowcoral.com
© Business Wire 2012
